Skip to content

Enhancing Social Interaction With an AlterEgo Artificial Agent

Enhancing Social Interaction With an AlterEgo Artificial Agent

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02879591
Acronym
ALTEREGO
Enrollment
246
Registered
2016-08-25
Start date
2014-04-30
Completion date
2016-09-30
Last updated
2016-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Brief summary

The objective of AlterEgo is the creation of an interactive cognitive architecture, implementable in various artificial agents, allowing a continuous interaction with patients suffering from social disorders, by virtue of changes in behavioural (robot-based) as well as morphological (avatar-based) properties of that agent. The project includes research in fundamental and clinical neurosciences, interaction modeling, development of new computer-vision techniques and human-robot interfaces, as well as evaluation of the scenarios with patients before, during, and after training sessions. At the end of the project, the investigators will produce a new avatar-based clinical method able to enhance social interaction of patients. The first challenge of this project is to create an avatar alter ego of a patient. Based on recent work in social robotics and neurosciences, the investigators hypothesize that if patients face artificial agents morphologically and behaviourally similar to them, they will increase their social interaction. The second challenge is to transform the morphology and the behaviour of the similar artificial agent into that of a healthy and different agent. The investigators assume that the smooth and continuous behavioural shift from similar/unhealthy to complementary/healthy social behaviour will lead to a better social rehabilitation. AlterEgo opens the door to a new generation of social artificial agents in service robotics. AlterEgo is an interdisciplinary project at the interaction of Social Motor Neurosciences (UM1), Robotics (EPFL), Complex Systems Dynamics (UOB), Computer Vision (DFKI), and Psychiatry (CHU). This project includes a set of experiments that started in april 2014 and will terminate in september 2016 before undergoing a randomised clinical research.

Interventions

OTHERSocial Skills training with Avatar therapist

Sponsors

Université Montpellier
CollaboratorOTHER
Ecole Polytechnique Fédérale de Lausanne
CollaboratorOTHER
University of Bristol
CollaboratorOTHER
DEUTSCHES FORSCHUNGSZENTRUM FUER KUENSTLICHE
CollaboratorUNKNOWN
University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients suffering from schizophrenia according to the criteria proposed in the DSM-IV-TR * Aged between 18 and 60 years old.

Exclusion criteria

* History of head trauma * History of neurological disorders (epilepsy disease, multiple sclerosis, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, stroke) * An actual ECT treatment * Substance Abuse and / or current Substance dependence (excluding tobacco and cannabis). * Pregnant women, new mothers and nursing mothers * People private of their liberty

Design outcomes

Primary

MeasureTime frameDescription
number of patient enhancing social intercation3 monthsimprovement of social interactions (interpersonal relations, items 1 to 7 on Specific Levels Of Functioning, SLOF)

Secondary

MeasureTime frame
number of patient accepting avatar therapy3 months
questionnaire for Faisability of avatar therapy3 months

Countries

France

Contacts

Primary ContactDelphine Capdevielle, MD, PhD
d-capdevielle@chu-montpellier.Fr0033467339727
Backup ContactStéphane Raffard, PhD
s-raffard@chu-montpellier.fr0033467339702

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026